Bayer New Zealand Ltd is inviting health technology start-up companies looking for support to bring their innovation to market to apply to the Grants4Apps Accelerator program.
The Grants4Apps Accelerator program is an initiative that was launched globally by Bayer HealthCare Pharmaceuticals in 2013 to encourage the development and realisation of innovations in software services, hardware, technologies, or apps that have the potential to create value for doctors and patients.
For the five chosen start-ups in 2015, the Grants4Apps Accelerator program will provide funding of €50,000 each, mentoring by Bayer experts as well as seasoned entrepreneurs and investors, plus office space for 100 days at Bayer HealthCare Pharmaceuticals headquarters in Berlin.
“Innovation is what drives Bayer and we are keen to support others in developing initiatives that can make a real difference to the lives of doctors and patients,” said Riaz Buksh, Bayer New Zealand Pharmaceuticals Country Head. “Bayer recognises the creative potential outside the company and believes that combining expertise is key to innovation and success.
“Complementing our own capabilities by establishing relationships with excellent partners from science and industry is an essential element of our strategy and one that adds great value at all levels and phases of our business.
“The Grants4Apps Accelerator creates an ideal environment to foster digital innovation in healthcare and is an excellent example of our engagement in open innovation.”
The Grants4Apps program is particularly looking for any integrated next-generation technology that supports patient adherence, diagnosis, therapy management or prevention. The application process is now open and closes on May 31st, 2015. The five successful start-ups from this year’s submissions will be travelling to Berlin for the intense ‘incubation’ at Bayer HealthCare Pharmaceuticals’ offices from 10th August until 4th December 2015.